The typical scheme employed when designing site saturation variant libraries

The best kept secret in drug discovery has a Twist

DNA synthesis

Home » Emerging technologies » DNA synthesis » Page 2

plant

Four synthetic biology startups to watch in 2019

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

DNA Script

DNA Script Creates U.S. Subsidiary and Expands Executive Team in the U.S.

Emily Leproust

A big IPO for synthetic biology: Twist rings the Nasdaq bell today

News Digest #247 – Twist’s IPO, Ginkgo’s Bioworks4, iGEM’s winners, and Geltor’s Series A

Twist Bioscience Corporation Announces Pricing of Initial Public Offering

Touchlight Genetics

Janssen Biotech and Touchlight announce collaboration

Twist Bioscience Adds Ray Tabibiazar, M.D., as Senior Vice President, Corporate Development and Business Strategy

Synpromics

Synpromics Promoter Technology Moves Closer to the Clinic

Synpromics

Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform